Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
11
NMPA:11
Drug Approvals
Phloroglucinol Injection
- Product Name
- 间苯三酚注射液
- Approval Number
- 国药准字H20253419
- Approval Date
- Feb 20, 2025
NMPA
Olopatadine Hydrochloride Eye Drops
- Product Name
- 盐酸奥洛他定滴眼液
- Approval Number
- 国药准字H20249046
- Approval Date
- Oct 16, 2024
NMPA
Rivastigmine Bitartrate Oral Solution
- Product Name
- 重酒石酸利斯的明口服溶液
- Approval Number
- 国药准字H20244630
- Approval Date
- Aug 5, 2024
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20243429
- Approval Date
- Apr 7, 2024
NMPA
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20243416
- Approval Date
- Mar 29, 2024
NMPA
Levetiracetam Concentrated Solution for Injection
- Product Name
- 左乙拉西坦注射用浓溶液
- Approval Number
- 国药准字H20233679
- Approval Date
- Jun 7, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found